Why Viking Therapeutics Stock Popped Again Today

Cantor Fitzgerald thinks the GLP-1 diet drug VK2735 will be a "multi-blockbuster" for Viking stock.Shares of Viking Therapeutics (VKTX 10.83%) jumped 12.5% through 11:40 a.m. ET on Tuesday on further support from Wall Street analysts.Viking stock inched higher Monday after Truist Securities analyst Joon Lee lowered his price target, while predicting the company will benefit from phase 3 clinical trial news on its new VK2735 weigh loss drug. Today, the shares are advancing by leaps and bounds on an even more ...